By Admin | Published September 3, 2015 | Posted in Whistleblower Litigation | Tagged Tags: False Claims Act, off-label marketing, unlawful activity, whistleblower | Leave a comment
On June 19, the whistleblower in a False Claims Act suit argued that the court should take action to secure documents that demonstrate Abbott Laboratories encouraged off-label marketing and doctor kickbacks. The whistleblower and former Abbott employee, Amy Bergman, denied the company’s claims that documents have already been shared, and believes that evidence supporting her Read More
Read More